- Marketwired•5 days agoAPC Invents Quantitative Method for Assessing Pattern of Antibody Labeling Impacting the Emerging, Rapidly Growing Market for Antibody-Drug Conjugates (ADC)
Advanced Proteome Therapeutics Corporation is pleased to announce that it has invented a measurable basis for evaluating antibody labeling that provides key information on the pattern of...
- Marketwired•2 months agoAdvanced Proteome Therapeutics Corporation Obtains Option to License Antibody Candidates and Collaborates With CCAB to Jointly Fund Research
Advanced Proteome Therapeutics Corporation , a biopharmaceutical company dedicated to creating, developing, and commercializing innovative therapies, today announced that it has entered into an exclusive......
- Marketwired•2 months agoAdvanced Proteome Therapeutics Retains Virtus Advisory Group to Provide Corporate Communication Services
Advanced Proteome Therapeutics Corporation is pleased to announce that it has retained Virtus Advisory Group Inc. , to develop and implement a strategic corporate communications...
APC.V : Summary for ADVANCED PROTEOME THERAPEUTICS - Yahoo Finance
Advanced Proteome Therapeutics Corporation (APC.V)
TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
|Day's Range||0.04 - 0.05|
|52 Week Range||0.03 - 0.09|
|PE Ratio (TTM)||-9.17|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|